A Phase II Trial of Neoadjuvant Erlotinib (TARCEVA®) Followed by Surgery for Selected Patients with Stage IIIA, N2-Positive Non-Small Cell Lung Cancer

被引：0

作者：

Lim, Taekyu ^{[1
]}

Baek, Kyung Kee ^{[1
]}

Yi, Jun Ho ^{[1
]}

Sin, Jong-Mu ^{[1
]}

Lee, Jeeyun ^{[1
]}

Park, Yeon Hee ^{[1
]}

Ahn, Jin Seok ^{[1
]}

Ahn, Myung-Ju ^{[1
]}

Park, Keunchil ^{[1
]}

机构：

[1] Samsun Med Ctr, Dept Hematol Oncol, Seoul, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S394 / S394

页数：1

共 50 条

[1] PIT-3: A multicenter phase II trial of erlotinib induction followed by surgery in stage IIIA (N2) EGFR mutated non-small cell lung cancer
Takamochi, K.
Suzuki, K.
Tsuboi, M.
Niho, S.
Oyamada, S.
Yamaguchi, T.
Tanaka, F.
Maniwa, Y.
Shiono, S.
Ito, H.
Haruki, T.
Suzuki, H.
Ikeda, N.
Watanabe, H.
Okada, M.
ANNALS OF ONCOLOGY, 2024, 35 : S797 - S797
[2] Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
Noh, Jae Myoung
Ahn, Yong Chan
Lee, Hyebin
Pyo, Hongryull
Kim, BoKyong
Oh, Dongryul
Park, Hyojung
Lee, Eonju
Park, Keunchil
Ahn, Jin Seok
Ahn, Myung-Ju
Sun, Jong-Mu
CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 645 - 652
[3] Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial
Stupp, Roger
Mayer, Michael
Kann, Roger
Weder, Walter
Zouhair, Abderahim
Betticher, Daniel C.
Roth, Arnaud D.
Stahel, Rolf A.
Majno, Sabine Balmer
Peters, Solange
Jost, Lorenz
Furrer, Markus
Thierstein, Sandra
Schmid, Ralph A.
Hsu-Schmitz, Shu-Fong
Mirimanoff, Rene-Olivier
Ris, Hans-Beat
Pless, Miklos
LANCET ONCOLOGY, 2009, 10 (08): : 785 - 793
[4] A prospective phase II study of induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
Zhong, Wenzhao
Yang, Xuening
Liao, Riqiang
Nie, Qiang
Su, Jian
Chen, Zhihong
Zhang, Xuchao
An, Shejuan
Zhou, Qing
Yang, Jinji
Wu, Yi Long
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[5] Erlotinib (Tarceva) for advanced non-small cell lung cancer
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1205): : 25 - 26
[6] Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
Shin, Sumin
Kim, Hong Kwan
Cho, Jong Ho
Choi, Yong Soo
Kim, Kwhanmien
Kim, Jhingook
Zo, Jae Ill
Sun, Jong-Mu
Ahn, Myung-Ju
Park, Keunchil
Pyo, Hongryull
Ahn, Yong Chan
Shim, Young Mog
JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2602 - 2613
[7] Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients
Tsukioka, Takuma
Izumi, Nobuhiro
Mizuguchi, Shinjiro
Kyukwang, Chung
Komatsu, Hiroaki
Toda, Michihito
Hara, Kantaro
Miyamoto, Hikaru
Nishiyama, Noritoshi
GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2018, 66 (12) : 716 - 722
[8] Upfront surgery is essential in selected patients with stage IIIA non-small cell lung cancer
Zheng, Difan
Chen, Haiquan
JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : E815 - E816
[9] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
De Marinis, Filippo
Gebbia, V.
De Petris, L.
ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
[10] Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients
Takuma Tsukioka
Nobuhiro Izumi
Shinjiro Mizuguchi
Chung Kyukwang
Hiroaki Komatsu
Michihito Toda
Kantaro Hara
Hikaru Miyamoto
Noritoshi Nishiyama
General Thoracic and Cardiovascular Surgery, 2018, 66 : 716 - 722

← 1 2 3 4 5 →